Bank of Montreal Can Increases Stake in Amgen Inc.

The Canadian bank now owns over 1 million shares of the biotech giant.

Published on Mar. 11, 2026

Got story updates? Submit your updates here. ›

Bank of Montreal Can, a Canadian financial institution, has increased its holdings in Amgen Inc. (NASDAQ:AMGN) by 5.3% during the 3rd quarter of 2026. The firm now owns 1,063,079 shares of the medical research company's stock, worth approximately $300 million.

Why it matters

Amgen is a major player in the biotechnology industry, developing and manufacturing important therapeutic drugs. Bank of Montreal Can's increased stake in the company signals the bank's confidence in Amgen's long-term growth potential.

The details

According to a recent 13F filing with the Securities and Exchange Commission, Bank of Montreal Can added 53,566 shares of Amgen to its portfolio during the 3rd quarter. This represents a 5.3% increase in the bank's total holdings of the biotech firm's stock.

  • Bank of Montreal Can increased its Amgen stake during the 3rd quarter of 2026.

The players

Bank of Montreal Can

A Canadian financial institution that has increased its ownership stake in Amgen Inc.

Amgen Inc.

A global biotechnology company that develops and manufactures therapeutic drugs.

Got photos? Submit your photos here. ›

The takeaway

Bank of Montreal Can's increased investment in Amgen signals the bank's confidence in the biotech company's long-term growth prospects. This move highlights the continued interest from institutional investors in the pharmaceutical and biotechnology sectors.